Skip to content

In the BioHarmony Drug Report Database

Asparaginase

Elspar, Spectrila (asparaginase) is an enzyme pharmaceutical. Asparaginase was first approved as Elspar on 1978-01-10. It is used to treat cholelithiasis, lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma.
Trade Name Spectrila
Common Name Asparaginase
Indication cholelithiasis, lymphoma, precursor cell lymphoblastic leukemia-lymphoma
Drug Class Enzymes
Asparaginase
Get full access now